Screener
Vor Biopharma VOR Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Vor Biopharma’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220689
| (in thousands, except share and per share amounts) | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total current assets | 500,778 | 458,105 |
| Restricted cash | 168 | 168 |
| Property and equipment, net | 565 | 533 |
| Operating lease right-of-use assets | 2,827 | 2,936 |
| Other assets | 2,408 | 2,384 |
| Total assets | $506,746 | $464,126 |
| Liabilities and stockholders’ deficit | ||
| Current liabilities: |
Item 1. Financial Statements (Unaudited).
FAQ
- What is Vor Biopharma's operating lease ROU assets?
- Vor Biopharma (VOR) reported operating lease ROU assets of $2.83M in Q1 2026.
- How has Vor Biopharma's operating lease ROU assets changed year-over-year?
- Vor Biopharma's operating lease ROU assets decreased by 91.6% year-over-year, from $33.7M to $2.83M.
- What is the long-term trend for Vor Biopharma's operating lease ROU assets?
- Over 5 years (2020 to 2025), Vor Biopharma's operating lease ROU assets has grown at a -29.7% compound annual growth rate (CAGR), from $17.12M to $2.94M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Vor Biopharma's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude